Abstract
THE development of blood cells including expansion of megakaryocyte progenitor cells requires the interplay of marrow stromal cells and polypeptide cytokines1–10. Recently, characterization of c-Mpl, the receptor encoded by the proto-oncogene c-mpl, revealed structural homology with the haematopoietic cytokine receptor family11, and its involvement in megakaryocyte development12 We report here that the ligand for c-Mpl13 is relatively lineage specific, works both alone and synergistically with early acting cytokines to support megakaryocyte colony formation, and acts at a late stage of development to increase megakaryocyte size, polyploidization and expression of differentiation markers. In vivo, c-Mpl ligand stimulates platelet production by greatly expanding marrow and splenic megakaryocytes and their progenitors, and by shifting the distribution of megakaryocyte ploidy to higher values. Thus, as c-Mpl ligand has the expected characteristics of the major regulator of megakaryocyte development, we propose that it be termed thrombopoietin.
Similar content being viewed by others
References
Metcalf, D. Trends biochem. Sci. 17, 286–289 (1992).
Ogawa, M. Blood 81, 2844–2853 (1993).
Mayani, H., Guilbert, L. J. & Janowska-Wieczorek, A. Eur. J. Haemat. 49, 225–233 (1992).
Leary, A. G., Zeng, H. Q., Clark, S. C. & Ogawa, M. Proc. natn. Acad. Sci. U.S.A. 89, 4013–4017 (1992).
Whetton, A. D. & Dexter, T. M. Curr. Opin. Cell Biol. 5, 1044–1049 (1993).
Ishibashi, T. et al. Proc. natn. Acad. Sci. U.S.A. 86, 5953–5957 (1989).
Debili, N. et al. Blood 82, 84–95 (1993).
Teramura, M., Kobayashi, S., Hoshino, S., Oshimi, K. & Mizoguchi, H. Blood 79, 327–331 (1992).
Han, Z. C., Bellucci, S., Wan, H. Y. & Caen, J. P. Br. J. Haemat. 81, 1–5 (1992).
Avraham, H. et al. Blood 80, 1679–1684 (1992).
Vignon, I. et al. Proc. natn. Acad. Sci. U.S.A. 89, 5640–5644 (1992).
Methia, N., Louache, F., Vainchenker, W. & Wendling, F. Blood 82, 1395–1401 (1993).
Lok, S. et al. Nature 369, 565–568 (1994).
Foster, D. C., Holly, R. D., Sprecher, C. A., Walker, K. M. & Kumar, A. A. Biochemistry 30, 367–372 (1991).
Tsukada, K. et al. Blood 81, 866–867 (1993).
Avanzi, G. C. et al. Br. J. Haemat. 69, 359–366 (1988).
Carrington, P. A. et al. Blood 77, 34–41 (1991).
Geissler, K. et al. Blood 79, 1155–1160 (1992).
Ishibashi, T. et al. Blood 74, 1241–1244 (1989).
Neben, T. Y. et al. Blood 81, 901–908 (1993).
Chow, F-P. R., Zsebo, K. & Hamburger, A. W. Expl Hemat. 21, 255–262 (1993).
Hill, R. J., Levin, J. & Levin, F. C. Expl Hemat. 20, 354–360 (1992).
Jelkmann, W. Physiol. Rev. 72, 449–489 (1992).
Broudy, V. C., Tait, J. F. & Powell, J. S. Arch. Biochem. Biophys. 265, 329–336 (1988).
Burstein, S. A., Friese, P., Downs, T. & Mei, R. Expl Hemat. 20, 1170–1177 (1992).
Jackson, C. W., Brown, L. K., Somerville, B. C., Lyles, S. A. & Look, A. T. Blood 63, 768–778 (1984).
Canfield, F. A., Ozols, J., Nugent, D. & Roth, G. J. Biochem. biophys. Res. Commun. 147, 526–534 (1987).
Lee, M., Durch, S., Dale, D. & Finch, C. Blood 53, 619–632 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaushansky, K., Lok, S., Holly, R. et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369, 568–571 (1994). https://doi.org/10.1038/369568a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/369568a0
- Springer Nature Limited
This article is cited by
-
Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation
Bone Marrow Transplantation (2023)
-
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial
Annals of Hematology (2023)
-
Genomic Variation Affecting MPV and PLT Count in Association with Development of Ischemic Stroke and Its Subtypes
Molecular Neurobiology (2023)
-
Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner
Nature Communications (2023)
-
Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials
Stem Cell Research & Therapy (2022)